Daily as of 3 Nov 16:00 ET
- Price
- below both $159.89 vs 50 $233.41 / 200 $283.48
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 11 Feb 2026 · projected 30 bars out
ALNY | Alnylam PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$159.89
+$1.89 (+1.20%)
Alnylam Pharmaceuticals (ALNY) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat below the 200 on the daily since Feb 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $165.00 vs 50 $304.47 / 200 $258.44
- Projection
- 💀Death cross projected in 11 bars
- Test
- No active test
- Last cross
- 🟨Golden cross week of 29 Jul 2024 · projected 6 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $159.89 vs 50 $218.36 / 200 $249.56
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 12 Dec 2025 · projected 14 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 11 Feb 2026 | 💀Death steep | daily | 30 bars out | Not tested |
| 12 Dec 2025 | 💀Death | 4-hour | 14 bars out | Not tested |
| 29 May 2025 | 🟨Golden moderate | daily | 19 bars out | Not tested |
| 16 May 2025 | 🟨Golden | 4-hour | 13 bars out | — |
| 17 Apr 2025 | 💀Death | 4-hour | 15 bars out | — |
About ALNY
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$346M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge